7c ) after treatment with lomustine (CCNU), JNJ10198400 and cyclosporine-treated high-neural glioblastoma cells, whereas talazoparib showed a trend for greater sensitivity in low-neural glioblastoma cells; however, none of these compounds reached statistical significance (Extended Data Fig. 7d ).
1
—
—